title: Treatment of severe hemorrhagic cystitis after allogeneic stem cell transplantation with palifermin, a recombinant human keratinocyte growth factor.
authors.forename: Akos
authors.initials: A
authors.lastname: Czibere
authors.forename: Ingmar
authors.initials: I
authors.lastname: Bruns
authors.forename: Thorsten
authors.initials: T
authors.lastname: Graef
authors.forename: Roland
authors.initials: R
authors.lastname: Fenk
authors.forename: Fabian
authors.initials: F
authors.lastname: Zohren
authors.forename: Nancy
authors.initials: N
authors.lastname: Safaian
authors.forename: Mirko
authors.initials: M
authors.lastname: Mueller
authors.forename: Rainer
authors.initials: R
authors.lastname: Haas
authors.forename: Guido
authors.initials: G
authors.lastname: Kobbe
mesh_terms: D000328:Adult; D003556:Cystitis / Q000188:drug therapy* / Q000209:etiology; D051523:Fibroblast Growth Factor 7 / Q000008:administration & dosage*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014184:Transplantation, Homologous
chemical_list: D051523:Fibroblast Growth Factor 7